Knowthestock.com
SYK - Stryker Corp.
SNP 500

Hold

Strong Growth and Improving
WeakStrong
WeakStrong

68%

based on last 5 year data.
Income Statement is STRONG
Revenue Growth is 10.51%
Operating Income Growth is 26.71%
Net Income Growth is 38.88%
Earnings Per Share (EPS) Growth is 38.43%
Net Margin is 16.34%
Balance Sheet is WEAK
Current Asset to Current Liability Ratio is 1.91
Debt Ratio is 0.54
Current Debt to Net Income Ratio is 2.59
Total Debt to Total Assets Ratio is 0.35
Cash Flow is STRONG
Cash from Operations Growth is 20.5%
Capital Expenditure is Low
Net Increase in Cash is Positive
Long Term Score Trend is POSITIVE
Investment Risk is High
based on last 4 quarter data.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Stryker Corp. (SYK) - www.stryker.com
Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Exchange - NEW YORK STOCK EXCHANGE INC.
Industry - Surgical and Medical Instrument Manufacturing
Sector - Manufacturing
CEO - Kevin Lobo
Employees - 2,020
    Close

    Login/Register

    Home


Cookie Policy
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2024 and future.